Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin-Reference-Cited by-同舟云学术

Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin

Published:2022-03 Issue:5 Volume:10 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiological Reports

Author:

Theurey Pierre¹^ORCID,Vial Guillaume²,Fontaine Eric³,Monternier Pierre‐Axel¹,Fouqueray Pascale¹,Bolze Sébastien¹,Moller David E.¹,Hallakou‐Bozec Sophie¹

Affiliation:

1. Poxel SA Lyon France

2. University Grenoble‐Alpes INSERM U1300, Hypoxia and PhysioPathology (HP2) Laboratory Grenoble France

3. Laboratory of Fundamental and Applied Bioenergetics INSERM U1055 Grenoble University Grenoble France

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.15151

Reference43 articles.

1. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

2. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

3. In Vitro Investigation, Pharmacokinetics, and Disposition of Imeglimin, a Novel Oral Antidiabetic Drug, in Preclinical Species and Humans

4. Metformin-associated lactic acidosis: Current perspectives on causes and risk

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin;Medical Principles and Practice;2024-08-12

2. RETRACTED: Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice;Life Sciences;2024-03

3. Imeglimin: the New Kid on the Block;Current Diabetes Reports;2023-12-05

4. DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-UHPLC METHOD FOR THE ESTIMATION OF IMEGLIMIN HYDROCHLORIDE USED FOR THE TREATMENT OF METABOLIC DISORDER DIABETES MELLITUS;International Journal of Applied Pharmaceutics;2023-11-07

5. Mitochondrial Dysfunction and Imeglimin: A New Ray of Hope for the Treatment of Type-2 Diabetes Mellitus;Mini-Reviews in Medicinal Chemistry;2023-10-10